Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
57.05
-1.30 (-2.23%)
Oct 8, 2025, 2:35 PM AST

TADAWUL:9620 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
20.0719.8618.0317.01
Revenue Growth (YoY)
6.77%10.11%6.04%-
Cost of Revenue
10.9710.479.878.7
Gross Profit
9.19.388.178.31
Selling, General & Admin
4.094.694.154.68
Other Operating Expenses
----0.11
Operating Expenses
4.064.273.824.58
Operating Income
5.045.124.343.73
Interest Expense
-0.09-0.07-0.09-0.1
Pretax Income
4.975.044.263.63
Income Tax Expense
0.290.260.10.12
Net Income
4.694.784.163.51
Net Income to Common
4.694.784.163.51
Net Income Growth
21.47%14.85%18.47%-
Shares Outstanding (Basic)
111-
Shares Outstanding (Diluted)
111-
Shares Change (YoY)
31.65%38.36%--
EPS (Basic)
4.094.685.64-
EPS (Diluted)
4.094.685.64-
EPS Growth
-7.73%-16.99%--
Free Cash Flow
3.575.27-1.744.53
Free Cash Flow Per Share
3.125.16-2.36-
Dividend Per Share
-3.000--
Gross Margin
45.34%47.26%45.29%48.87%
Operating Margin
25.10%25.77%24.09%21.95%
Profit Margin
23.37%24.07%23.08%20.66%
Free Cash Flow Margin
17.78%26.55%-9.65%26.61%
EBITDA
5.976.055.174.63
EBITDA Margin
29.73%30.45%28.65%27.25%
D&A For EBITDA
0.930.930.820.9
EBIT
5.045.124.343.73
EBIT Margin
25.10%25.77%24.09%21.95%
Effective Tax Rate
5.74%5.24%2.27%3.32%
Advertising Expenses
-0.430.360.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.